Please use this identifier to cite or link to this item:
https://doi.org/10.1002/ana.21405
| Title: | Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease | Authors: | Ross, O.A. Wu, Y.-R. Lee, M.-C. Funayama, M. Chen, M.-L. Soto, A.I. Mata, I.F. Lee-Chen, G.-J. Chiung, M.C. Tang, M. Zhao, Y. Hattori, N. Farrer, M.J. Tan, E.-K. Wu, R.-M. |
Issue Date: | Jul-2008 | Citation: | Ross, O.A., Wu, Y.-R., Lee, M.-C., Funayama, M., Chen, M.-L., Soto, A.I., Mata, I.F., Lee-Chen, G.-J., Chiung, M.C., Tang, M., Zhao, Y., Hattori, N., Farrer, M.J., Tan, E.-K., Wu, R.-M. (2008-07). Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Annals of Neurology 64 (1) : 88-92. ScholarBank@NUS Repository. https://doi.org/10.1002/ana.21405 | Abstract: | Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LKRK2 variants in sporadic Parkinson's disease. © 2008 American Neurological Association. Published by Wiley-Liss, Inc., through Wiley Subscription Services. | Source Title: | Annals of Neurology | URI: | http://scholarbank.nus.edu.sg/handle/10635/109929 | ISSN: | 03645134 | DOI: | 10.1002/ana.21405 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.